Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
23Andme Holding Co.
(NQ:
ME
)
0.3690
+0.0215 (+6.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 23Andme Holding Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
23andMe Announces Poster Presentations on 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2023 Annual Meeting
September 27, 2023
23andMe to present data on efficacy and safety and dose selection for the ongoing 23ME-00610 Phase 1/2a clinical trial in patients with advanced solid malignancies
From
23andMe, Inc.
Via
GlobeNewswire
23andMe and Sickle Cell 101 Collaborate to Expand Sickle Cell Awareness Program
September 14, 2023
From
23andMe, Inc.
Via
GlobeNewswire
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care....
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
23andMe Holding's Return On Capital Employed Overview
May 26, 2023
Via
Benzinga
Recap: 23andMe Holding Q4 Earnings
May 25, 2023
Via
Benzinga
23andMe Holding's Earnings Outlook
May 24, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Explode In Q3
September 06, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Why Olin Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 01, 2023
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) surged 181.1% to $3.63. TradeUP Acquisition Corp. (NASDAQ: UPTD) gained 148.5% to $18.14.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 01, 2023
Via
Benzinga
Why Dell Technologies Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
September 01, 2023
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 53.4% to $0.2147 in pre-market trading after the company announced it received an Underwriting Clearance Notice for a $70 million coupon.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 31, 2023
Via
Benzinga
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
August 31, 2023
From
23andMe, Inc.
Via
GlobeNewswire
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe
August 25, 2023
Both businesses have a lot to prove.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why 23andMe Holding Stock Plummeted by 13% Today
August 09, 2023
Investors reacted sharply and not well to the company's inaugural set of fiscal 2024 earnings.
Via
The Motley Fool
23andMe Reports FY2024 First Quarter Financial Results
August 08, 2023
From
23andMe, Inc.
Via
GlobeNewswire
23andMe to Report FY2024 First Quarter Financial Results
July 25, 2023
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin
July 20, 2023
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks
June 21, 2023
With millions of Americans experiencing mental health symptoms, 23andMe+ members now have exclusive access to four mental health reports to help determine their genetic likelihood of having one of...
From
23andMe, Inc.
Via
GlobeNewswire
3 Gene Testing Stocks to Buy Before They Take Off
June 17, 2023
The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.
Via
InvestorPlace
23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
May 25, 2023
From
23andMe, Inc.
Via
GlobeNewswire
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
May 23, 2023
Neither has a traditional business model, but that could be an asset for both.
Via
The Motley Fool
3 Key Biotech Trends for 2023 And Beyond
May 19, 2023
New opportunities are becoming apparent, but so are fresh risks in the biotech field.
Via
The Motley Fool
Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke.
May 19, 2023
Explore the world of high-risk penny stocks, with their potential for significant returns, as we analyze three speculative opportunities.
Via
InvestorPlace
New 23andMe survey reveals nine out of ten physicians in the U.S. believe genetics play an important part of a patient’s complete health picture
May 16, 2023
From
23andMe, Inc.
Via
GlobeNewswire
3 Personalized Medicine Stocks to Buy for Long-Time Returns
May 15, 2023
Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.
Via
InvestorPlace
23andMe to Report FY2023 Fourth Quarter and Full Year Financial Results
May 11, 2023
From
23andMe Holding Co.
Via
GlobeNewswire
23andMe Releases New Report Revealing Likelihood of Developing Lupus
May 09, 2023
23andMe+ members can now gain insights on the chronic autoimmune condition
From
23andMe Holding Co.
Via
GlobeNewswire
Reza Afkhami Joins 23andMe as Chief Corporate Development Officer
May 08, 2023
Afkhami joins 23andMe with more than 20 years of experience in corporate development and strategy
From
23andMe Holding Co.
Via
GlobeNewswire
BELLUS Health, Sunrun And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
April 18, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1
April 14, 2023
From
23andMe Holding Co.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.